Movement Alert｜PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff

Market Focus06-29

On June 29, PegBio rose 17.94% in regular trading, trading at HK$5.86/share, with turnover of HK$97.03 million.

On the news front, the company completed its H-share full circulation on June 25, converting approximately 101.7 million previously unlisted shares into H-shares, which began trading on June 26. Following the conversion, H-shares as a proportion of total issued shares increased from 72.69% to 98.70%, while unlisted shares dropped from 106.8 million to just 5.09 million. The sudden influx of tradable shares created concentrated selling pressure on June 26, driving the stock to a historic low of HK$4.96. After the prior session absorbed the bulk of liquidation from newly unlocked shareholders, the stock staged a sharp technical rebound from depressed levels.

PegBio is a biotechnology company focused on developing innovative therapies for chronic diseases, with its core product Paidakang receiving marketing approval in November 2025 and a commercialization partnership with Tenry Pharmaceutical targeting cumulative sales exceeding RMB 10 billion.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1110775924?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 11:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110775924","market":"hk","top_or_hot":-1,"title":"Movement Alert｜PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff","media":"Market Focus","content":"<p><p>On June 29, PegBio rose 17.94% in regular trading, trading at HK$5.86/share, with turnover of HK$97.03 million.</p><p>On the news front, the company completed its H-share full circulation on June 25, converting approximately 101.7 million previously unlisted shares into H-shares, which began trading on June 26. Following the conversion, H-shares as a proportion of total issued shares increased from 72.69% to 98.70%, while unlisted shares dropped from 106.8 million to just 5.09 million. The sudden influx of tradable shares created concentrated selling pressure on June 26, driving the stock to a historic low of HK$4.96. After the prior session absorbed the bulk of liquidation from newly unlocked shareholders, the stock staged a sharp technical rebound from depressed levels.</p><p>PegBio is a biotechnology company focused on developing innovative therapies for chronic diseases, with its core product Paidakang receiving marketing approval in November 2025 and a commercialization partnership with Tenry Pharmaceutical targeting cumulative sales exceeding RMB 10 billion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-29 11:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 29, PegBio rose 17.94% in regular trading, trading at HK$5.86/share, with turnover of HK$97.03 million.</p><p>On the news front, the company completed its H-share full circulation on June 25, converting approximately 101.7 million previously unlisted shares into H-shares, which began trading on June 26. Following the conversion, H-shares as a proportion of total issued shares increased from 72.69% to 98.70%, while unlisted shares dropped from 106.8 million to just 5.09 million. The sudden influx of tradable shares created concentrated selling pressure on June 26, driving the stock to a historic low of HK$4.96. After the prior session absorbed the bulk of liquidation from newly unlocked shareholders, the stock staged a sharp technical rebound from depressed levels.</p><p>PegBio is a biotechnology company focused on developing innovative therapies for chronic diseases, with its core product Paidakang receiving marketing approval in November 2025 and a commercialization partnership with Tenry Pharmaceutical targeting cumulative sales exceeding RMB 10 billion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1110775924","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110775924","pubTimestamp":1782702519,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 29, PegBio rose 17.94% in regular trading, trading at HK$5.86/share, with turnover of HK$97.03 million.On the news front, the company completed its H-share full circulation on June 25,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02565":"派格生物医药-B"},"translate_title":"异动快讯|培格生物常规交易涨17.94%H股全流通抛售后股价从历史低位反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02565":1},"content_text":"On June 29, PegBio rose 17.94% in regular trading, trading at HK$5.86/share, with turnover of HK$97.03 million.On the news front, the company completed its H-share full circulation on June 25, converting approximately 101.7 million previously unlisted shares into H-shares, which began trading on June 26. Following the conversion, H-shares as a proportion of total issued shares increased from 72.69% to 98.70%, while unlisted shares dropped from 106.8 million to just 5.09 million. The sudden influx of tradable shares created concentrated selling pressure on June 26, driving the stock to a historic low of HK$4.96. After the prior session absorbed the bulk of liquidation from newly unlocked shareholders, the stock staged a sharp technical rebound from depressed levels.PegBio is a biotechnology company focused on developing innovative therapies for chronic diseases, with its core product Paidakang receiving marketing approval in November 2025 and a commercialization partnership with Tenry Pharmaceutical targeting cumulative sales exceeding RMB 10 billion.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1110775924","isCrawlerRequest":true}